Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation

Andhra Medical College

Status and phase: Completed; Phase 3

Conditions: Atrial Fibrillation

Treatments: Drug: oral carvedilol

Study type: Interventional

Funder types: Other

Identifiers

NCT02832089

01AMCRVC

Details and patient eligibility

About

Oral carvedilol administered in escalating doses in patients with atrial fibrillation among patients with AF with fast ventricular rate.

Full description

Patients with AF with FVR of any etiology were evaluated and given escalating doses of oral carvedilol in doses - 3.125mg OD, then 3.125 bid, then 6.25mg bid, then 12.5mg bid. The ECG was recorded regularly and analysed for rate reduction or control.

Enrollment: 30 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• AF with fast ventricular rate

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

active arm

Experimental group

Description:

single arm study with one group given oral carvedilol.

Treatment:

Drug: oral carvedilol